Stone Run Capital, LLC Axogen, Inc. Transaction History
Stone Run Capital, LLC
- $269 Billion
- Q3 2024
A detailed history of Stone Run Capital, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Stone Run Capital, LLC holds 73,500 shares of AXGN stock, worth $929,040. This represents 0.38% of its overall portfolio holdings.
Number of Shares
73,500
Previous 23,000
219.57%
Holding current value
$929,040
Previous $167 Million
518.83%
% of portfolio
0.38%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$51.7 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$41.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$38 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$36.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$30.7 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $534M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...